PLA2G4A (pS505) blocking peptide

Blocking peptide binds specifically to the target antibody and block undesirable antibody binding. This occurs because the peptide resembles the epitope for which the antibody is specific, therefore, the antibody binds to the blocking peptide are no longer able to bind to the epitope in the protein.

Pre-adsorption with blocking peptide greatly improves the results and it is extremely useful in immunohistochemistry (IHC) or in Western blotting (immunobloting) when non-specific binding is an issue.

This peptide is recommended to block anti-PLA2G4A (pS505) Antibody (Catalog no. 4073287) reactivity

Directions for Use: Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4°C for overnight or at room temperature for 2 hours
Catalog No.5173287
Unit Size 1mg
Product CategoryBlocking Peptide
Gene Symbol PLA2G4A
UniProt ID P47712
Purity >85%
Synonyms CPLA2; PLA2G4; Cytosolic phospholipase A2; cPLA2; Phospholipase A2 group IVA
Storage/Stability -20°C/1 year
Shipping Gel Packs

Available Size & Price Options

Select Qty

DescriptionSizeQuantity
No Product in Quote List.